EQL Pharma AB (FRA:7JK) Cyclically Adjusted Book per Share: €0.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7JK EQL Pharma AB FRA:7JK
60 GF Score
Price €2.00
! 4 Warning Signs
View Full Analysis

What is EQL Pharma AB Cyclically Adjusted Book per Share?

EQL Pharma AB FRA:7JK -2.40% 60 Cyclically Adjusted Book per Share is €0.42 as of Mar. 2026. GuruFocus rates FRA:7JK with a GF Score™ of 60/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

EQL Pharma AB's adjusted book value per share for the three months ended in Mar. 2026 was €0.840. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.42 for the trailing ten years ended in Mar. 2026.

During the past 12 months, EQL Pharma AB's average Cyclically Adjusted Book Growth Rate was 19.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of EQL Pharma AB was 18.90% per year. The lowest was 18.90% per year. And the median was 18.90% per year.

As of today (2026-07-15), EQL Pharma AB's current stock price is €1.996. EQL Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €0.42. EQL Pharma AB's Cyclically Adjusted PB Ratio of today is 4.75.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of EQL Pharma AB was 23.30. The lowest was 4.91. And the median was 16.53.


EQL Pharma AB  (FRA:7JK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

EQL Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.996/0.42
=4.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of EQL Pharma AB was 23.30. The lowest was 4.91. And the median was 16.53.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


EQL Pharma AB Cyclically Adjusted Book per Share Related Terms


EQL Pharma AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for EQL Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB Cyclically Adjusted Book per Share Chart

EQL Pharma AB Annual Data
Trend Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.25 0.26 0.37 0.42

EQL Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.38 0.40 0.42 0.42

FRA:7JK vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Cyclically Adjusted PB Ratio falls into.


FRA:7JK
60GF Score
EQL Pharma AB FRA:7JK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EQL Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EQL Pharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.84/133.5600*133.5600
=0.840

Current CPI (Mar. 2026) = 133.5600.

EQL Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201603 0.215 100.751 0.285
201606 0.215 101.019 0.284
201609 0.209 101.138 0.276
201612 0.231 102.022 0.302
201703 0.226 102.022 0.296
201706 0.220 102.752 0.286
201709 0.228 103.279 0.295
201803 0.210 103.962 0.270
201806 0.208 104.875 0.265
201809 0.209 105.679 0.264
201812 0.265 105.912 0.334
201903 0.256 105.886 0.323
201906 0.253 106.742 0.317
201909 0.255 107.214 0.318
201912 0.265 107.766 0.328
202003 0.256 106.563 0.321
202006 0.302 107.498 0.375
202009 0.315 107.635 0.391
202012 0.330 108.296 0.407
202103 0.309 108.360 0.381
202106 0.319 108.928 0.391
202109 0.336 110.338 0.407
202112 0.392 112.486 0.465
202203 0.404 114.825 0.470
202206 0.425 118.384 0.479
202209 0.441 122.296 0.482
202212 0.471 126.365 0.498
202303 0.475 127.042 0.499
202306 0.477 129.407 0.492
202309 0.484 130.224 0.496
202312 0.532 131.912 0.539
202403 0.540 132.205 0.546
202406 0.573 132.716 0.577
202409 0.600 132.304 0.606
202412 0.622 132.987 0.625
202503 0.694 132.825 0.698
202506 0.721 133.699 0.720
202509 0.800 133.480 0.800
202512 0.840 133.390 0.841
202603 0.840 133.560 0.840

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.42 mean?
EQL Pharma AB (FRA:7JK) has a Cyclically Adjusted Book per Share of €0.42 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on EQL Pharma AB and its competitors.
Is EQL Pharma AB's Cyclically Adjusted Book per Share too high?
EQL Pharma AB's current Cyclically Adjusted Book per Share is €0.42. Overall, EQL Pharma AB has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does EQL Pharma AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
EQL Pharma AB's Cyclically Adjusted Book per Share of €0.42 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on EQL Pharma AB and its competitors. EQL Pharma AB's current Cyclically Adjusted Book per Share is €0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EQL Pharma AB stock overvalued right now?
EQL Pharma AB (FRA:7JK) has a current Cyclically Adjusted Book per Share of €0.42. The current Cyclically Adjusted Book per Share is €0.42. EQL Pharma AB's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For EQL Pharma AB (FRA:7JK), the current Cyclically Adjusted Book per Share is €0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EQL Pharma AB Business Description

Other Exchanges EQL:Sweden7JK:Germany
Address Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company focused on efficiently and thoughtfully developing and marketing generic drugs. The company operates in one segment, which is medicine. Its niche generics are divided into four parts based on four sales and marketing models: Retail, Hospital, Branded, and Tests. EQL Pharma specializes in identifying, developing, and selling generics, i.e., medicines that are medically equivalent to originator medicines. The company operates in Sweden, Denmark, Norway, Finland, the rest of Europe, and outside Europe, generating the majority of its revenue from Sweden.
60GF Score

Get the complete analysis for FRA:7JK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.00
Price